MIGLITOL
Miglitol helps adults with type 2 diabetes manage their blood sugar levels alongside diet and exercise. It is primarily used to lower blood sugar spikes that occur after eating, providing an additional layer of control for patients who need help managing their glucose. This medication can be used alone or combined with other therapies like sulfonylureas to improve overall glycemic management.
How MIGLITOL Works
This drug works by reversibly blocking enzymes in the small intestine that break down complex sugars into simple glucose. By slowing this digestive process, it delays the absorption of sugar into the bloodstream, which prevents sharp rises in blood glucose after meals. Unlike some other diabetes medications, it achieves this without stimulating the body to produce more insulin.
Details
- Status
- Prescription
- First Approved
- 2015-02-24
- Routes
- ORAL
- Dosage Forms
- TABLET
MIGLITOL Approval History
What MIGLITOL Treats
1 indicationsMIGLITOL is approved for 1 conditions since its original approval in 2015. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Type 2 Diabetes
MIGLITOL Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in MIGLITOL's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications MIGLITOL treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to MIGLITOL
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT01099839 | 1941-CL-0062 | Ph 1 | completed | A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MIGLITOL FDA Label Details
Indications & Usage
MIGLITOL is indicated for the treatment of Type 2 Diabetes.
Looking for the branded version?
GLYSET
Full clinical data, patents, trials, and competitive landscape for miglitol.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.